INDIAN BENCHMARKS slump after FDA bans US imports from 2 plants
INDIAN EQUITY BENCHMARKS fell to its lowest closing level in nearly two and a half months on Wednesday as caution ahead of the expiry of monthly derivatives and the end of the fiscal year hit blue-chips. The S&P BSE Sensex and CNX Nifty ended 0.18%-0.14% lower each.
SBI expects credit growth to pick up to 15% in FY16
Sun Pharma-Ranbaxy merger completed
Rolta India enters into MoU with Hitachi India
The crucial resistance for Nifty is now seen at 8635 and above this 8695. Support for the immediate term is now placed at 8490 and next support will be 8435.
Get Free Share Market Tips, MCX Tips Free Trial, NCDEX Tips, Commodity Tips, Nifty Futures Tips with profitable calls and tips.
0 comments:
Post a Comment